Inflammation triggers constitutive activity and agonist-induced negative responses at M 3 muscarinic receptor in dental pulp

Journal of Endodontics

Volumn 37, Issue 2, 2011, Pages 185-190

  Sterin Borda, Leonor ^a,b   Orman, Betina ^a   De Couto Pita, Alejandra ^a   Borda, Enri ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Argentine Research National Council ^*  (Argentina)

Author keywords

Binding assay; constitutive receptor activity; dental pulp; M 3 muscarinic receptor; nitric oxide synthase; pilocarpine; pulpitis

Indexed keywords

MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; NITRIC OXIDE SYNTHASE; PILOCARPINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; DRUG POTENTIATION; INFLAMMATION; INVERSE AGONISM; MALE; METABOLISM; PROTEIN CONFORMATION; PULPITIS; RAT; SIGNAL TRANSDUCTION; TOOTH PULP; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; DENTAL PULP; DISEASE MODELS, ANIMAL; DRUG INVERSE AGONISM; INFLAMMATION; MALE; MUSCARINIC AGONISTS; NITRIC OXIDE SYNTHASE; PILOCARPINE; PROTEIN CONFORMATION; PULPITIS; RATS; RATS, WISTAR; RECEPTOR, MUSCARINIC M3; SIGNAL TRANSDUCTION;

EID: 78751490054     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2010.11.021     Document Type: Article

References (37)

1. L. Olgart, G.D. Kostouros, and L. Edwall Local actions of acetylcholine on vasomotor regulation in rat incisor pulp Acta Physiol Scand 158 1996 311 316
2. G. Bergenholtz, S. Nagaoka, and M. Jontell Class II antigen expressing cells in experimentally induced pulpitis Int Endod J 24 1991 8 14
3. M. Närhi, and T. Hirvonen Functional changes in cat pulp nerve activity after thermal and mechanical injury of the pulp Proc Finn Dent Soc 79 1983 162 167
4. S.F. Maier, L.E. Goehler, M. Fleshner, and L.R. Watkins The role of the vagus nerve in cytokine-to-brain communication Ann New York Acad Sci 840 1998 289 300
5. P. Photo, and R. Antila Innervation of blood vessels in the dental pulp Int Dent J 22 1972 228 239
6. 2 reciprocal interactions in rat dental pulp: cholinoceptor modulation J Endod 33 2007 142 147
7. J. Luthman, G. Luthman, and T. Höldelt Occurrence and distribution of different neurochemical markers in the human dental pulp Arch Oral Biol 37 1992 193 208
8. L. Edwall, L. Olgart, and G. Haegerstam Influence of vasodilator substances on pulpal blood flow in the cat Acta Odontol Scand 31 1973 289 296
9. E. Okabe, K. Todoki, and H. Ito Direct pharmacological action of vasoactive substances on pulpal blood flow: an analysis and critique J Endod 15 1989 473 477
10. M. Liu, S. Kim, D. Park, K. Markowitz, G. Bilotto, and J. Dorscher-Kim Comparison of the effect of intra-arterial an locally applied vasoactive agents on pulpal blood flow in dog canine teeth determined by laser Doppler velocimetry Arch Oral Biol 35 1990 405 410
11. L. Sterin-Borda, C. Furlan, S. Reina, B. Orman, and E. Borda Differential signalling pathways involved in cholinoceptor-dependent stimulation of nitric oxide isoforms in dental pulp Int Endod J 40 2007 544 552
12. A. De Couto Pita, D. Passafaro, S. Ganzinelli, E. Borda, and L. Sterin-Borda Differential cholinoceptor modulatyion of nitric oxide isoforms in experimentally induced inflammation of dental pulp tissue Int Endod J 42 2009 525 533
13. 2 and metalloproteinase-3 production in experimentally-induced inflammation of rat dental pulp J Endod 35 2009 529 536
14. H.N. Kawanishi, N. Kawashima, N. Suzuki, H. Suda, and M. Takagi Effects of an inducible nitric oxide synthase inhibitor on experimentally induced rat pulpitis Eur J Oral Sci 112 2004 332 337
15. T. Kenakin The physiological significance of constitutive receptor activity Trends Pharmacol Sci 26 2005 603 605
16. K.A. Berg, J.A. Harvey, U. Spampinato, and W.P. Clarke Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors Trends Pharmacol Sci 26 2005 625 630
17. T. Costa, and S. Cotecchia Historical review: negative efficacy and the constitutive activity of G-protein-coupled receptors Trends Pharmacol Sci 26 2005 618 624
18. 3 chimeric G protein-coupled receptor Mol Pharmacol 64 2003 1474 1484
19. 3 receptor unmasks differences in the pharmacology of anticholinergics J Pharm Exp Ther 333 2010 201 209
20. 2 muscarinic acetylcholine receptor J Pharmacol Exp Ther 316 2006 279 288
21. M.R. Dowling, J.M. Willets, D.C. Budd, S.J. Charlton, S.R. Nahorski, and R.A. Challiss A single point mutation (N514Y) in the human M3 muscarinic acetylcholine receptor reveals differences in the properties of antagonists: evidence for differential inverse agonism J Pharmacol Exp Ther 317 2006 1134 1142
22. 3 muscarinic acetylcholine receptors in the regulation of second messenger and extracellular signal-regulated kinases signalling pathway in Chinese hamster ovary cells Br J Pharmacol 138 2003 1340 1350
23. G. Hilf, and K.H. Jakobs Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membrane Eur J Pharmacol 225 1992 245 252
24. R. Hanf, Y. Li, G. Szabo, and R. Fischmeister Agonist-independent effects of muscarinic antagonists on calcium and potassium currents in frog and rat cardiac cells J Physiol 461 1993 743 765
25. P.J. Barnes Distribution of receptor targets in the lung Proc Am Thorac Soc 1 2004 345 351
26. P.J. Barnes The role of anticholinergics in chronic obstructive pulmonary disease Am J Med 117 Suppl 12A 2004 S24 S32
27. N. Kawashima, H.N. Kawanishi, N. Suzuki, M. Takagi, and H. Suda Effect of NOS inhibitor on cytokine and COX2 expression in rat pulpitis J Dent Res 84 2005 762 767
28. L. Sterin-Borda, A. Vila Echagüe, C. Perez Leiros, A. Genaro, and E. Borda Endogenous nitric oxide signaling system and the cardiac muscarinic acetylcholine receptor-inotropic response Br J Pharmacol 115 1995 1525 1531
29. K.J. Gregory, N.E. Hall, A.B. Tobin, P.M. Sexton, and A. Christopoulos Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias J Biol Chem 285 2010 7459 7474
30. F. Di Nardo Di Maio, Z. Lohinai, and C. D'Arcangelo Nitric oxide synthase in healthy and inflamed human dental pulp J Dent Res 83 2004 312 316
31. U. Gether, J.A. Ballesteros, R. Seifert, E. Sanders-Bush, H. Weinstein, and B.K. Kobilka Structural instability of a constitutively active G-protein coupled receptor agonist-independent activation due to conformational flexibility J Biol Chem 272 1997 2587 2590
32. R.A. de Light, A.P. Kouriunakis, and A.P. Lizerman Inverse agonism at G protein-coupled receptors: (patho) physiological relevance and implications for drug discovery Br J Pharmacol 130 2000 1 12
33. A.M. Spiegel Defects in G-protein coupled signal transduction in human disease Annu Rev Physiol 58 1996 143 170
34. A. Shenker, L. Laue, S. Kosugi, J.J. Merendino, T. Minegishi, and G.B. Cutler A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty Nature 365 1993 652 654
35. J. Lyons, C.A. Landis, and G. Harsh Two G protein oncogenes in human endocrine tumors Science 249 1990 655 659
36. L.S. Weinstein, P.V. Gejman, P. de Mazancourt, N. American, and A.M. Spiegel A heterozygous 4-bp deletion mutation in the Gs alpha gene (GNAS1) in a patient with Albright hereditary osteodystrophy Genomics 13 1992 1319 1321
37. L.F. Allen, R.J. Lefkowitz, M.G. Caron, and S. Cotecchia G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity Proc Natl Acad Sci 88 1991 11354 11358